Cardio Diagnostics Holdings Inc
CDIO1.290USD
+0.240+22.86%
Handelsschluss 02/06, 16:00（ET）Kurse um 15 Minuten verzögert
2.28MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Cardio Diagnostics Holdings Inc Unternehmen
Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development, and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.
Cardio Diagnostics Holdings Inc Informationen
BörsenkürzelCDIO
Name des UnternehmensCardio Diagnostics Holdings Inc
IPO-datumNov 23, 2021
CEODogan (Meeshanthini V)
Anzahl der mitarbeiter13
WertpapierartOrdinary Share
GeschäftsjahresendeNov 23
Addresse311 W. Superior Street
StadtCHICAGO
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl60645
Telefon18552269991
Website
BörsenkürzelCDIO
IPO-datumNov 23, 2021
CEODogan (Meeshanthini V)
Führungskräfte von Cardio Diagnostics Holdings Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
4.28K
--
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
3.87K
+1.00%
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
3.25K
+1.00%
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
2.39K
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Paul F. Burton, J.D.
Mr. Paul F. Burton, J.D.
Independent Director
Independent Director
--
--
Ms. Wendy J. Betts
Ms. Wendy J. Betts
Independent Director
Independent Director
--
--
Mr. Peter K. Fung
Mr. Peter K. Fung
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
4.28K
--
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
3.87K
+1.00%
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
3.25K
+1.00%
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
2.39K
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Umsatzaufteilung
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Aktionärsstatistik
Aktualisiert: Sat, Jan 31
Aktualisiert: Sat, Jan 31
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Dogan (Meeshanthini)
3.02%
Bd Holding, Inc
2.90%
BlackRock Institutional Trust Company, N.A.
1.95%
The Vanguard Group, Inc.
1.32%
Citadel Advisors LLC
1.07%
Andere
89.74%
Aktionäre
Aktionäre
Anteil
Dogan (Meeshanthini)
3.02%
Bd Holding, Inc
2.90%
BlackRock Institutional Trust Company, N.A.
1.95%
The Vanguard Group, Inc.
1.32%
Citadel Advisors LLC
1.07%
Andere
89.74%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
4.40%
Individual Investor
3.90%
Corporation
2.90%
Hedge Fund
1.12%
Investment Advisor/Hedge Fund
0.83%
Andere
86.86%
Institutionelle Beteiligung
Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
39
115.09K
6.22%
--
2025Q3
41
115.09K
6.70%
+30.25K
2025Q2
39
84.84K
5.90%
+274.00
2025Q1
35
84.57K
5.41%
-9.47K
2024Q4
39
85.72K
5.08%
+29.79K
2024Q3
59
55.93K
19.52%
-4.45K
2024Q2
61
60.37K
27.33%
+6.29K
2024Q1
58
54.08K
29.21%
-151.37K
2023Q4
58
55.21K
23.41%
+40.18K
2023Q3
53
15.03K
36.07%
+2.55K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Dogan (Meeshanthini)
55.18K
3.02%
--
--
Aug 25, 2025
Bd Holding, Inc
52.88K
2.9%
--
--
Aug 25, 2025
BlackRock Institutional Trust Company, N.A.
35.57K
1.95%
--
--
Sep 30, 2025
The Vanguard Group, Inc.
24.12K
1.32%
+11.44K
+90.22%
Sep 30, 2025
Citadel Advisors LLC
19.52K
1.07%
+19.52K
--
Sep 30, 2025
DRW Securities, LLC
18.16K
0.99%
+18.16K
--
Sep 30, 2025
Geode Capital Management, L.L.C.
15.10K
0.83%
+1.73K
+12.97%
Sep 30, 2025
Dogan (Timur)
4.28K
0.23%
--
--
Aug 25, 2025
Hosseinion (Warren)
3.87K
0.21%
+1.00
+0.03%
Aug 25, 2025
Philibert (Robert)
3.25K
0.18%
+1.00
+0.03%
Aug 25, 2025
Mehr Anzeigen
Verbundene ETFs
Name
Anteil
Keine Daten
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
May 08, 2025
Merger
30→1
Datum
Ex-Dividendentag
Art
Verhältnis
May 08, 2025
Merger
30→1
